Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer

By Wist Erik   Sommer Hilde   Østenstad Bjørn   Risberg Terje   Bremnes Yngve   Mjaaland Ingvild  

Acta Oncologica, Vol. 43, Iss. 2, 2004-03 ,pp. : 186-189

Informa Healthcare

Access to resources Recommend Favorite

Capecitabine monotherapy in patients with anthracycline-and taxane-pretreated metastatic breast cancer

By Lee S.-H.   Lee J.   Park J.   Park S.   Lee K.-E.   Lee S.   Nam E.   Park J.   Kim K.   Jung C.   Park Y.   Yoon S.   Kang W.   Lee M.   Park K.   Im Y.-H.  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 223-231

Humana Press, Inc

Access to resources Recommend Favorite

A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer

By Minckwitz Gunter   Jonat Walter   Fasching Peter   Bois Andreas   Kleeberg Ulrich   Lück Hans-Joachim   Kettner Erika   Hilfrich Jörn   Eiermann Wolfgang   Torode Julie   Schneeweiss Andreas  

Breast Cancer Research and Treatment, Vol. 89, Iss. 2, 2005-01 ,pp. : 165-172

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane

By Smorenburg C.H.   Bontenbal M.   Seynaeve C.   Zuylen C.v.   Heus G.d.   Verweij J.   Wit R.d.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 1, 2001-03 ,pp. : 83-87

Springer Publishing Company

Access to resources Recommend Favorite

Vinorelbine and capecitabine in anthracycline- and/or taxane-pretreated metastatic breast cancer: sequential or combinational?

By Zhang Jian   Gu Shi-Yang   Gan Yu   Wang Zhong-Hua   Wang Bi-Yun   Guo Hai-Yi   Wang Jia-Lei   Wang Lei-Ping   Zhao Xin-Min   Hu Xi-Chun  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 103-113

Springer Publishing Company

Access to resources Recommend Favorite